BANK OF NEW YORK MELLON CORP – Regeneron Pharmaceuticals, Inc. Transaction History
BANK OF NEW YORK MELLON CORP portfolio value:
$704.52M
portfolio value
BANK OF NEW YORK MELLON CORP quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.77% | 64.86K shares | 138.30M | $688.87 | 1.02M |
| Q2 2022 | share | Increase | +4.45% | 40.79K shares | -74.27M | $591.13 | 957.85K |
| Q1 2022 | share | Increase | +3.74% | 33.03K shares | 82.21M | $698.42 | 917.05K |
| Q4 2021 | share | Increase | +0.36% | 3.20K shares | 25.22M | $642.51 | 884.02K |
| Q3 2021 | share | Increase | +2.59% | 22.2K shares | 53.48M | $605.18 | 880.81K |
| Q2 2021 | share | Increase | +1.49% | 12.57K shares | 79.27M | $558.54 | 858.61K |
| Q1 2021 | share | Increase | +2.15% | 17.77K shares | 154K | $473.14 | 846.03K |
| Q4 2020 | share | Increase | +0.99% | 8.13K shares | -58.94M | $483.11 | 828.26K |
| Q3 2020 | share | Increase | +6.08% | 46.97K shares | -23.08M | $559.78 | 820.12K |
| Q2 2020 | share | Increase | +26.22% | 160.58K shares | 183.06M | $623.65 | 773.15K |
| Q1 2020 | share | Increase | +1.98% | 11.88K shares | 73.56M | $488.29 | 612.56K |
| Q4 2019 | share | Decrease | -0.02% | -101 shares | 58.88M | $375.48 | 600.67K |
| Q3 2019 | share | Decrease | -0.34% | -2.03K shares | -22.02M | $277.4 | 600.77K |
| Q2 2019 | share | Decrease | -0.43% | -2.57K shares | -59.90M | $313 | 602.80K |
| Q1 2019 | share | Increase | +2.29% | 13.53K shares | 27.52M | $410.62 | 605.38K |
| Q4 2018 | share | Decrease | -2.17% | -13.10K shares | -23.36M | $373.5 | 591.84K |
| Q3 2018 | share | Increase | +1.26% | 7.52K shares | 38.31M | $404.04 | 604.94K |
| Q2 2018 | share | Increase | +0.18% | 1.05K shares | 738K | $344.99 | 597.42K |
| Q1 2018 | share | Decrease | -3.56% | -22.04K shares | -27.13M | $344.36 | 596.36K |
| Q4 2017 | share | Decrease | -4.13% | -26.60K shares | -55.90M | $375.96 | 618.40K |
| Q3 2017 | share | Decrease | -16.21% | -124.76K shares | -89.67M | $447.12 | 645.01K |
| Q2 2017 | share | Decrease | -12.71% | -112.08K shares | 36.33M | $491.14 | 769.78K |
| Q1 2017 | share | Increase | +36.79% | 237.15K shares | 105.06M | $387.51 | 881.86K |
| Q4 2016 | share | Increase | +0.19% | 1.25K shares | -22.01M | $367.09 | 644.71K |
| Q3 2016 | share | Decrease | -1.30% | -8.50K shares | 30.99M | $402.02 | 643.46K |
| Q2 2016 | share | Decrease | -2.93% | -19.67K shares | -14.4M | $349.23 | 651.96K |
| Q1 2016 | share | Decrease | -17.40% | -141.48K shares | -199.33M | $360.44 | 671.64K |